By Andy Extance
Hallucinogen-assisted psychiatric treatment heads to regulators, amid cost and other concerns
MDMA and psilocybin are to be offered to be patients suffering from intractable mental health conditions
By Maria Burke
Government action on of N2O goes against recommendations of drug advisory committee
Site powered by Webvision Cloud